Detalhe da pesquisa
1.
Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity.
Proc Natl Acad Sci U S A
; 120(3): e2207291120, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36634138
2.
Canadian Consensus Guidelines for the Diagnosis and Treatment of Autoimmune Encephalitis in Adults.
Can J Neurol Sci
; : 1-21, 2024 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38312020
3.
The Canadian Multiple Sclerosis Pregnancy Study: First-trimester miscarriages in women with multiple sclerosis.
Mult Scler
; 29(3): 407-414, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36683353
4.
A national case-control study investigating demographic and environmental factors associated with NMOSD.
Mult Scler
; 29(4-5): 521-529, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36803237
5.
Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging.
Mult Scler
; 28(3): 418-428, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34132126
6.
Adherence to laboratory monitoring among people taking oral drugs for multiple sclerosis: A Canadian population-based study.
Mult Scler
; 27(2): 239-249, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32141376
7.
Cervical cord myelin abnormality is associated with clinical disability in multiple sclerosis.
Mult Scler
; 27(14): 2191-2198, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33749378
8.
INVESTIGATING MICROANGIOPATHY USING SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN PATIENTS WITH SUSAC SYNDROME.
Retina
; 41(10): 2172-2178, 2021 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33758133
9.
Canadian Multiple Sclerosis Pregnancy Study (CANPREG-MS): Rationale and Methodology.
Can J Neurol Sci
; 47(1): 109-114, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31659949
10.
Long-Term Stability of Neuroaxonal Structure in Alemtuzumab-Treated Relapsing-Remitting Multiple Sclerosis Patients.
J Neuroophthalmol
; 40(1): 37-43, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32045393
11.
Predicting risk of secondary progression in multiple sclerosis: A nomogram.
Mult Scler
; 25(8): 1102-1112, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29911467
12.
Development and usability testing of a patient decision aid for newly diagnosed relapsing multiple sclerosis patients.
BMC Neurol
; 19(1): 173, 2019 Jul 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31325961
13.
Laboratory Monitoring Practices Among Canadian Multiple Sclerosis Clinicians.
Can J Neurol Sci
; 46(4): 389-393, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31111800
14.
Age Related Multiple Sclerosis Severity Score: Disability ranked by age.
Mult Scler
; 23(14): 1938-1946, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28155580
15.
MS arising during Tocilizumab therapy for rheumatoid arthritis.
Mult Scler
; 22(2): 254-6, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26743640
16.
Children of chronically ill parents: Relationship between parental multiple sclerosis and childhood developmental health.
Mult Scler
; 22(11): 1452-1462, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26683589
17.
Association between the use of selective serotonin reuptake inhibitors and multiple sclerosis disability progression.
Pharmacoepidemiol Drug Saf
; 25(10): 1150-1159, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27211481
18.
Progression rates and sample size estimates for PPMS based on the CLIMB study population.
Mult Scler
; 21(2): 180-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25070676
19.
Modeling probability of additional cases of natalizumab-associated JCV sero-negative progressive multifocal leukoencephalopathy.
Mult Scler
; 20(6): 757-60, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24189572
20.
An observational comparison of natalizumab vs. fingolimod using JCV serology to determine therapy.
Mult Scler
; 20(10): 1381-90, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24852928